Dallas, TX - Albumin in the urine at levels lower than those conventionally used to define microalbuminuria may be a risk factor for cardiovascular disease (CVD) even in patients without diabetes or ...
A machine learning–driven web tool based on 13 standard patient metrics demonstrates strong predictive performance for MASLD, ...
An expert discusses how chronic kidney disease (CKD), often underdiagnosed and poorly recognized, is intricately linked with cardiovascular and metabolic conditions, emphasizing the urgent need for ...
June 22, 2012 (Paris, France) — In an Austrian study of patients receiving peritoneal dialysis, researchers found that oral active vitamin D was associated with a lower risk forperitonitis and ...
Researchers develop an innovative mRNA vaccine delivery system with albumin-recruiting lipid nanoparticles, improving safety ...
A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication ...
Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback